Veteran private-equity and corporate finance executive with experience leading mid-market buyouts, operational turnarounds and portfolio management. James V. Thompson Jr. has held senior operating and investment roles across healthcare and business services, advising capital allocators on deal sourcing, due diligence and value creation strategies. Known for sector-focused diligence and governance oversight, often active with family offices and institutional LPs.
Veteran private-equity and corporate finance executive with experience leading mid-market buyouts, operational turnarounds and portfolio management. James V. Thompson Jr. has held senior operating and investment roles across healthcare and business services, advising capital allocators on deal sourcing, due diligence and value creation strategies. Known for sector-focused diligence and governance oversight, often active with family offices and institutional LPs.
Focuses on control-oriented mid-market buyouts and operational turnarounds with a sector lens on healthcare and business services. Emphasizes hands-on governance, rigorous sector-focused due diligence, and disciplined capital allocation that prioritizes cash-flow generation and EBITDA expansion. Pursues 3–7 year value-creation horizons driven by operational improvements, targeted add-on acquisitions, and selective strategic repositioning. Risk managed through conservative leverage, active board oversight, and measurable performance KPIs; partnership with family offices and institutional LPs to align incentives and co-invest on execution. Underwriting centers on repeatable models, margin recovery levers, and clear exit pathways to realize compounded returns from operational delta rather than multiple expansion alone.
Focuses on control-oriented mid-market buyouts and operational turnarounds with a sector lens on healthcare and business services. Emphasizes hands-on governance, rigorous sector-focused due diligence, and disciplined capital allocation that prioritizes cash-flow generation and EBITDA expansion. Pursues 3–7 year value-creation horizons driven by operational improvements, targeted add-on acquisitions, and selective strategic repositioning. Risk managed through conservative leverage, active board oversight, and measurable performance KPIs; partnership with family offices and institutional LPs to align incentives and co-invest on execution. Underwriting centers on repeatable models, margin recovery levers, and clear exit pathways to realize compounded returns from operational delta rather than multiple expansion alone.
| Trades 327 | Longs Won 223/327 68% | Profit Factor 20.81 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $237,095.16 |
| Average Win $63,747.19 | Best Trade (Jul 15) $3.28M | Sharpe Ratio -85.25 |
| Average Loss -$6,569.89 | Worst Trade (Jul 14) -$165,138.74 | Z-Score 4.81 (100%) |
| Commissions $0 | Avg. Trade Length 7m 3w 4d | Expectancy $41,383.35 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 27,027 | 24,324 | 21,622 | 18,919 | 16,216 | 13,514 | 10,811 | 8,108 | 5,405 | 2,703 |